Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 12:55 AM
Ignite Modification Date:
2025-12-25 @ 12:55 AM
NCT ID:
NCT00116467
Eligibility Criteria:
Inclusion Criteria:
* Initial diagnosis of de novo AML with no preexisting hematologic dysplasia for more than 3 months.
* No prior therapy except leukapheresis or less than 72 hours of hydroxyurea.
Exclusion Criteria:
* Prior myelodysplastic disorder, or treatment-related leukemia.
* Prior myeloproliferative disease.
* Acute promyelocytic leukemia (APL).
* Prior chemotherapy for a malignant or nonmalignant disorder.
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
60 Years
Study:
NCT00116467
Study Brief:
Protocol Section:
NCT00116467